Today marks 100 days since President Donald Trump took office — a period for the health care world that’s been distinguished ...

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

President Trump’s first 100 days has roiled health and science as part of the administration’s plan to reshape the federal ...